HUTCHMED (China) Limited (HCM.L)
GBp 236.0
(-3.28%)
GBp 236.0
(-3.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 536.38 Million USD | 36.63% |
| 2022 | 392.57 Million USD | 17.84% |
| 2021 | 333.14 Million USD | 62.38% |
| 2020 | 205.16 Million USD | 34.79% |
| 2019 | 152.21 Million USD | 26.99% |
| 2018 | 119.86 Million USD | 6.11% |
| 2017 | 112.96 Million USD | -18.36% |
| 2016 | 138.37 Million USD | 8.55% |
| 2015 | 127.47 Million USD | 28.69% |
| 2014 | 99.05 Million USD | 22.55% |
| 2013 | 80.83 Million USD | -35.76% |
| 2012 | 125.81 Million USD | 7.13% |
| 2011 | 117.44 Million USD | 28.89% |
| 2010 | 91.11 Million USD | 73.71% |
| 2009 | 52.45 Million USD | 56.43% |
| 2008 | 33.53 Million USD | 11.93% |
| 2007 | 29.95 Million USD | 29.89% |
| 2006 | 23.06 Million USD | -74.63% |
| 2005 | 90.89 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 508.85 Million USD | -5.13% |
| 2024 Q2 | 508.85 Million USD | 0.0% |
| 2023 FY | 536.38 Million USD | 36.63% |
| 2023 Q1 | 497.48 Million USD | 26.72% |
| 2023 Q4 | 536.38 Million USD | 0.0% |
| 2023 Q2 | 497.48 Million USD | 0.0% |
| 2023 Q3 | 536.38 Million USD | 7.82% |
| 2022 Q1 | 342.48 Million USD | 2.8% |
| 2022 FY | 392.57 Million USD | 17.84% |
| 2022 Q4 | 392.57 Million USD | 0.0% |
| 2022 Q3 | 392.57 Million USD | 14.63% |
| 2022 Q2 | 342.48 Million USD | 0.0% |
| 2021 FY | 333.14 Million USD | 62.38% |
| 2021 Q1 | 228.72 Million USD | 11.48% |
| 2021 Q2 | 259.19 Million USD | 13.32% |
| 2021 Q3 | 333.14 Million USD | 28.53% |
| 2021 Q4 | 333.14 Million USD | 0.0% |
| 2020 Q2 | 158.51 Million USD | 0.0% |
| 2020 Q3 | 205.16 Million USD | 29.43% |
| 2020 Q4 | 205.16 Million USD | 0.0% |
| 2020 FY | 205.16 Million USD | 34.79% |
| 2020 Q1 | - USD | -100.0% |
| 2019 FY | 152.21 Million USD | 26.99% |
| 2019 Q2 | 122.17 Million USD | -12.07% |
| 2019 Q4 | 152.21 Million USD | 30.88% |
| 2019 Q3 | 116.3 Million USD | -4.81% |
| 2019 Q1 | 138.94 Million USD | 15.92% |
| 2018 Q2 | 120.09 Million USD | 0.0% |
| 2018 Q4 | 119.86 Million USD | 0.0% |
| 2018 FY | 119.86 Million USD | 6.11% |
| 2018 Q1 | - USD | -100.0% |
| 2017 FY | 112.96 Million USD | -18.36% |
| 2017 Q1 | 133.19 Million USD | -3.74% |
| 2017 Q2 | 133.19 Million USD | 0.0% |
| 2017 Q3 | 112.96 Million USD | -15.19% |
| 2017 Q4 | 112.96 Million USD | 0.0% |
| 2016 Q2 | 123.67 Million USD | 0.0% |
| 2016 FY | 138.37 Million USD | 8.55% |
| 2016 Q4 | 138.37 Million USD | 0.0% |
| 2016 Q3 | 138.37 Million USD | 11.89% |
| 2016 Q1 | 123.67 Million USD | -2.98% |
| 2015 Q3 | 119.18 Million USD | 12.11% |
| 2015 FY | 127.47 Million USD | 28.69% |
| 2015 Q4 | 127.47 Million USD | 6.96% |
| 2015 Q1 | 106.3 Million USD | 7.32% |
| 2015 Q2 | 106.3 Million USD | 0.0% |
| 2014 Q4 | 99.05 Million USD | 0.0% |
| 2014 Q1 | 98.34 Million USD | 21.67% |
| 2014 FY | 99.05 Million USD | 22.55% |
| 2014 Q2 | 98.34 Million USD | 0.0% |
| 2013 Q4 | 80.83 Million USD | 3.06% |
| 2013 Q1 | 77.82 Million USD | -38.15% |
| 2013 FY | 80.83 Million USD | -35.76% |
| 2013 Q2 | 77.82 Million USD | 0.0% |
| 2013 Q3 | 78.43 Million USD | 0.79% |
| 2012 FY | 125.81 Million USD | 7.13% |
| 2012 Q2 | 121.03 Million USD | 0.0% |
| 2012 Q4 | 125.81 Million USD | 62.29% |
| 2012 Q3 | 77.52 Million USD | -35.95% |
| 2011 Q4 | 117.44 Million USD | 0.0% |
| 2011 FY | 117.44 Million USD | 28.89% |
| 2010 Q4 | 91.11 Million USD | 0.0% |
| 2010 FY | 91.11 Million USD | 73.71% |
| 2010 Q2 | 69.81 Million USD | 0.0% |
| 2009 FY | 52.45 Million USD | 56.43% |
| 2009 Q4 | 52.45 Million USD | 0.0% |
| 2008 FY | 33.53 Million USD | 11.93% |
| 2007 FY | 29.95 Million USD | 29.89% |
| 2006 FY | 23.06 Million USD | -74.63% |
| 2005 FY | 90.89 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|